Marie‐Clotilde Bernard

An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates

Manon Ripoll, Marie‐Clotilde Bernard, Céline Vaure et al. · Biomaterials · 2022 · 75 citations · Full text

Pharmacy, Biotechnology, Infectious Diseases +17

The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system

Marie‐Clotilde Bernard, Emilie Bazin, Nadine Petiot et al. · Molecular Therapy — Nucleic Acids · 2023 · 55 citations · Full text

Pharmacy, Immunology, Molecular Pharmaceutics +17

AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice

Catherine Caillet, Fabienne Piras, Marie‐Clotilde Bernard et al. · Vaccine · 2010 · 53 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine

Maryann Giel–Moloney, Ana P. Goncalvez, John Catalan et al. · Scientific Reports · 2018 · 44 citations · Full text

Life Sciences, Biotechnology, Infectious Diseases +17

Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs

Marie‐Clotilde Bernard, Véronique Barban, Fabrine Pradezynski et al. · PLoS ONE · 2015 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17